Literature DB >> 20822352

Anti-cocaine vaccine development.

Berma M Kinsey1, Thomas R Kosten, Frank M Orson.   

Abstract

Cocaine abuse is an ongoing and serious problem that has led to the growth of a brutal criminal enterprise, particularly in the Americas and Europe. At present, there are no effective pharmacological agents available to treat the addiction by blocking cocaine or reversing its effects. In order to help motivated addicts conquer their addiction, vaccines against cocaine are being developed and one has progressed to clinical trials. This article will discuss the concept of antidrug vaccines in general, the successes and limitations of the various anti-cocaine vaccine approaches, the results of the clinical trials with an anti-cocaine vaccine and some new vaccine-mediated approaches to combat cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20822352      PMCID: PMC2936703          DOI: 10.1586/erv.10.102

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  44 in total

1.  Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys.

Authors:  L Koetzner; S Deng; T L Sumpter; M Weisslitz; R T Abner; D W Landry; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

2.  Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010.

Authors:  K M Kantak; S L Collins; J Bond; B S Fox
Journal:  Psychopharmacology (Berl)       Date:  2001-01       Impact factor: 4.530

3.  Cocaine vaccines: antibody protection against relapse in a rat model.

Authors:  M R Carrera; J A Ashley; B Zhou; P Wirsching; G F Koob; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Cocaine catalytic antibodies: the primary importance of linker effects.

Authors:  M Matsushita; T Z Hoffman; J A Ashley; B Zhou; P Wirsching; K D Janda
Journal:  Bioorg Med Chem Lett       Date:  2001-01-22       Impact factor: 2.823

5.  Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.

Authors:  F Falugi; R Petracca; M Mariani; E Luzzi; S Mancianti; V Carinci; M L Melli; O Finco; A Wack; A Di Tommaso; M T De Magistris; P Costantino; G Del Giudice; S Abrignani; R Rappuoli; G Grandi
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

6.  An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis.

Authors:  S Isomura; P Wirsching; K D Janda
Journal:  J Org Chem       Date:  2001-06-15       Impact factor: 4.354

Review 7.  Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo: a clarification.

Authors:  A Warner; A B Norman
Journal:  Ther Drug Monit       Date:  2000-06       Impact factor: 3.681

Review 8.  From cocaine to ropivacaine: the history of local anesthetic drugs.

Authors:  Y A Ruetsch; T Böni; A Borgeat
Journal:  Curr Top Med Chem       Date:  2001-08       Impact factor: 3.295

Review 9.  Therapeutic vaccines for substance dependence.

Authors:  Thomas R Kosten; Diane Biegel
Journal:  Expert Rev Vaccines       Date:  2002-10       Impact factor: 5.217

10.  A second-generation vaccine protects against the psychoactive effects of cocaine.

Authors:  M R Carrera; J A Ashley; P Wirsching; G F Koob; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  21 in total

Review 1.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

Review 2.  Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

Authors:  Diwahar Narasimhan; James H Woods; Roger K Sunahara
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 3.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

4.  Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

5.  Enzyme-therapy approaches for the treatment of drug overdose and addiction.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2011-01       Impact factor: 3.808

6.  Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.

Authors:  Therese A Kosten; Xiaoyun Y Shen; Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Am J Addict       Date:  2014-09-22

Review 7.  Environmental, genetic and epigenetic contributions to cocaine addiction.

Authors:  R Christopher Pierce; Bruno Fant; Sarah E Swinford-Jackson; Elizabeth A Heller; Wade H Berrettini; Mathieu E Wimmer
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

8.  Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities.

Authors:  M Pravetoni; D E Keyler; R R Pidaparthi; F I Carroll; S P Runyon; M P Murtaugh; C A Earley; P R Pentel
Journal:  Biochem Pharmacol       Date:  2011-11-15       Impact factor: 5.858

9.  Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.

Authors:  J J Taylor; M Laudenbach; A M Tucker; M K Jenkins; M Pravetoni
Journal:  J Immunol Methods       Date:  2014-01-23       Impact factor: 2.303

10.  Probing the effects of hapten stability on cocaine vaccine immunogenicity.

Authors:  Xiaoqing Cai; Timothy Whitfield; Amira Y Moreno; Yanabel Grant; Mark S Hixon; George F Koob; Kim D Janda
Journal:  Mol Pharm       Date:  2013-10-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.